A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 9, Issue 12, Pages 1120-1126
Publisher
Oxford University Press (OUP)
Online
2015-09-09
DOI
10.1093/ecco-jcc/jjv156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease
- (2015) Avegail Flores et al. DIGESTIVE DISEASES AND SCIENCES
- Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD
- (2015) Konstantinos Papamichael et al. INFLAMMATORY BOWEL DISEASES
- Systematic review with meta-analysis: inflammatory bowel disease in the elderly
- (2014) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mo1179 Efficacy and Safety of Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease
- (2014) Triana Lobatón Ortega et al. GASTROENTEROLOGY
- Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease
- (2014) Iris Dotan et al. INFLAMMATORY BOWEL DISEASES
- Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis
- (2014) David Kevans et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway
- (2013) James C. Lee et al. CELL
- Targeting TNF-α for the treatment of inflammatory bowel disease
- (2013) Thomas Billiet et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease
- (2013) Jason W. Harper et al. INFLAMMATORY BOWEL DISEASES
- Risk Matrix for Prediction of Advanced Disease in a Population-based Study of Patients with Crohnʼs Disease (the IBSEN Study)
- (2013) Inger C. Solberg et al. INFLAMMATORY BOWEL DISEASES
- Using Genetic Prediction from Known Complex Disease Loci to Guide the Design of Next-Generation Sequencing Experiments
- (2013) Luke Jostins et al. PLoS One
- Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
- (2012) N. Vande Casteele et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
- (2012) Luke Jostins et al. NATURE
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Safety
- (2011) Gert Van Assche et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Predicting the outcome of ankylosing spondylitis therapy
- (2011) N. Vastesaeger et al. ANNALS OF THE RHEUMATIC DISEASES
- Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease
- (2011) Carlos González-Juanatey et al. ARTHRITIS RESEARCH & THERAPY
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?
- (2010) Geert R D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Disease Activity, ANCA and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis
- (2010) Matthias Jürgens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Neuropeptides, Mesenteric Fat, and Intestinal Inflammation
- (2009) Iordanes Karagiannides et al. Annals of the New York Academy of Sciences
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started